Skip to main content
Top
Published in: Arthritis Research & Therapy 1/2012

Open Access 01-12-2012 | Poster presentation

Maintenance of mitochondrial DNA copy number is essential for osteoclast survival

Authors: Tsuyoshi Miyazaki, Shuuichi Mori, Kazuhiro Shigemoto, Nils-Goran Larsson, Takeshi Nakamura, Shigekaki Kato, Tomoki Nakashima, Hiroshi Takayanagi, Sakae Tanaka

Published in: Arthritis Research & Therapy | Special Issue 1/2012

Login to get access

Excerpt

There is accumulating evidence that osteoclasts, the primary cells responsible for bone resorption, are involved in bone and joint destruction in rheumatoid arthritis. Bone resorption is highly regulated by mature osteoclast function as well as osteoclastogenesis. The life span of mature osteoclasts is relatively short both in vitro and in vivo, and once differentiated, they rapidly die in the absence of supporting cell or growth factors. Mitochondria is known as powerhouse of cell because they generate most of the cell's supply of adenosine triphosphate (ATP), used as a source of chemical energy. In addition to supplying cellular energy, mitochondria are involved in a range of other processes, such as signaling, cellular differentiation, cell growth, and cell death. Transcription and replication of mitochondrial DNA (mtDNA) are important steps in mitochondrial biogenesis and mitochondrial transcription factor A (Tfam) is essential for mtDNA transcription and replication. However, the functional significance of mitochondria has not been established in osteoclastic bone resorption. …
Metadata
Title
Maintenance of mitochondrial DNA copy number is essential for osteoclast survival
Authors
Tsuyoshi Miyazaki
Shuuichi Mori
Kazuhiro Shigemoto
Nils-Goran Larsson
Takeshi Nakamura
Shigekaki Kato
Tomoki Nakashima
Hiroshi Takayanagi
Sakae Tanaka
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue Special Issue 1/2012
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar3650

Other articles of this Special Issue 1/2012

Arthritis Research & Therapy 1/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.